Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/4/2020
SIETES contiene 92957 citas

 
 
 1 a 20 de 98 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Robertson K, Marshman LAG, Plummer D, Downs E. Effect of gabapentin vs pregabalin on pain intensity in adults ith chronic sciatica: a randomized clinical trial. JAMA Neurology 2018:15 de octubre. [Ref.ID 102863]
3.Enlace a cita original Cita con resumen
Klein LR, Driver BE, Miner JR, Martel ML, Hessel M, Collins JD, Horton GB, Fagerstrom E, Satpathy R, Cole JB. Intramuscular midazolam, olanzapine, ziprasidone, or haloperidol for treating acute agitation in the emergency department. Ann Emerg Med 2018:6 de junio. [Ref.ID 102665]
4. Cita con resumen
Laatikainen O, Mietttunen J, Sneck S, Lehtiniemi H, Tenhunen O, Turpeinen M. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis. Eur J Clin Pharmacol 2017;73:1539-49. [Ref.ID 102145]
5. Cita con resumen
Russo EB. Cannabidiol claims and misconceptions. Trends Pharmacol Sci 2017;38:198-201. [Ref.ID 101988]
6. Cita con resumen
Lin MLM, Robinson PD, Flank J, Sung L, Dupuis LL. The safety of metoclopramide in children: a systematic review and meta-analysis. Drug Saf 2016;39:675-87. [Ref.ID 100476]
7. Cita con resumen
Booth JN, Behring M, Cantor RS, Colantonio LD, Davidson S, Donnelly JP, Johnson E, Jordan K, Singleton C, Xie F, McGwin G. Zolpidem use and motor vehicle collisions in older drivers . Sleep Medicine 2015:29 de diciembre. [Ref.ID 99807]
8. Cita con resumen
Nosè M, Recla E, Trifirò G, Barbui C. Antipsychotic drug exposure and risk pneumonia: a systematic review and meta-analysis of observational studies. Pharmacoepidemiol Drug Saf 2015;24:agosto. [Ref.ID 99472]
9. Cita con resumen
Moynihan R. Evening the score on sex drugs: feminist movement or marketing masquerade?. BMJ 2014;349:g6246. [Ref.ID 98287]
10. Cita con resumen
Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014;370:444-54. [Ref.ID 97065]
11. Cita con resumen
Anónimo. Dexmedetomidine hydrochloride and cardiovascular events. Australian Prescriber 2013;36:134. [Ref.ID 95892]
12.Tiene citas relacionadas Cita con resumen
Devanand DP, Schultz SK, Sultzer DL. Discontinuation of risperidone in Alzheimer's disease. Author/editor response. N Engl J Med 2013;368:187-8. [Ref.ID 94751]
13.Tiene citas relacionadas Cita con resumen
Ling SM, Bonner AF, McMullen TL. Discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2013;368:187. [Ref.ID 94750]
14.Tiene citas relacionadas Cita con resumen
Power GA. Discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2013;368:186-7. [Ref.ID 94749]
15.Tiene citas relacionadas Cita con resumen
Gnjidic D, Hilmer SN. Discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2013;368:186. [Ref.ID 94748]
16.Tiene citas relacionadas
Wunsch H. Weighing the costs and benefits of a sedative. JAMA 2012;307:1195-7. [Ref.ID 92535]
17.Tiene citas relacionadas Cita con resumen
Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J, for the Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012;307:1151-60. [Ref.ID 92533]
18. Cita con resumen
19. Cita con resumen
Palm U, Geiger J, Lieb M. Emergence delirium after propofol anaesthesia. Eur J Clin Pharmacol 2011;67:209-10. [Ref.ID 90127]
20.Enlace a cita original Cita con resumen
Sury M, Bullock I, Rabar S, DeMott K. Sedation for diagnostic and therapeutic procedures in children and young people: summary of NICE guidance. BMJ 2011;342:45-9. [Ref.ID 90006]
Seleccionar todas
 
 1 a 20 de 98 siguiente >>